It is important to note that this activation occurs with endogenous protein levels of the signal transduction pathway, in non-cancerous, non-transformed cells, using modest doses of TGF-β (2 ng/ml), demonstrating this is a normal response and not related to over-expression artifacts or cancer induced mutations. Here, TGFB1 is linked to cancer.